Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 1

Grady Wulff
February 23, 2023

View both parts of the latest episode of our Meet the Analyst series where our Market Analyst, Grady Wulff, sits down with Dr. Tara Speranza, Healthcare & Biotech Analyst at Bell Potter, to discuss her outlook on the stocks she covers, Orthocell (ASX:OCC), Microba Life Sciences (ASX:MAP), and Monash IVF Group (ASX:MVF).

Take a look at Dr. Tara’s journey, her approach to analysing a company, and the first stock to be discussed, Orthocell (ASX:OCC).

In this video, Dr. Tara discusses:
– (0:59) Becoming a Bell Potter Analyst
– (2:56) Approaches to analysing a company
– (7:18) Orthocell’s global 25-year exclusive agreement
– (7:53) Orthocell’s TGA approval for its Remplir device
– (8:44) Orthocell’s speculative buy rating

Note: This interview was filmed on 7 February 2023.

 

View Part 2 here.

February Market Overview

Jessica Amir
February 28, 2020

Morning Bell 28 February

Jessica Amir
February 28, 2020

Morning Bell 27 February

Jessica Amir
February 27, 2020

Market Update 26 February

Jessica Amir
February 26, 2020

Morning Bell 25 February

Jessica Amir
February 25, 2020

Reporting season: Appen (ASX:APX)

Jessica Amir
February 24, 2020

Morning Bell 24 February

Paulina Peters
February 24, 2020

Weekly Wrap 21 February

Jessica Amir
February 21, 2020

Morning Bell 21 February

Jessica Amir
February 21, 2020